Indian drone makers see demand opportunity in border tensions, boost production

Anticipating a rise in demand for defence technologies due to escalating border tensions and deepening geopolitical unrest, Indian drone manufacturers such as IdeaForge, IG Drones, and Garuda Aerospace are boosting their production of surveillance and tactical systems.
The India-Pakistan conflict has seen both sides deploy drones for warfare and surveillance. The Indian defence forces are known to have deployed Israeli-made so-called suicide drones on 8 May. But given that the tensions are far from ebbing, Indian drone makers are looking to cater to an expected rise in demand for such defence technologies.
Also Read | US Army plans massive increase in its use of drones
"Our teams are currently deployed in the valley. Many of our customers already use our technology, so we remain on standby, ready to enhance their operational capabilities," Ankit Mehta, chief executive officer (CEO) of IdeaForge said, adding that due to the sensitive nature of the situation, the company is not privy to how the Indian armed forces are using their assets on the ground.
Mehta also refused to divulge details about the kind of drones - and quantity - that were being sought, saying that the information was sensitive.
Also Read | Drone startups looking beyond defence to serve agriculture, quick commerce
Similarly, IG Drones, a Delhi-based start-up, has ramped up manufacturing efforts in response to the growing demand for defence technology. Shuvam Dash, co-founder of IG Drones said that escalating border tensions have prompted the company to boost production.
Govt procurement
Likely procurements by the armed forces could provide some much-needed relief to drone companies, which have faced a slowdown due to delays in government contracts.
On Friday, IdeaForge reported a ₹26 crore loss in Q4 FY25, marking its third consecutive quarter of losses. Despite these setbacks, the company's operating revenue rose 15% quarter-on-quarter, reaching ₹20.3 crore. Interestingly, in Q4 FY25, civil contracts accounted for a massive 96% of the company's revenue, with defence contracts contributing just 4%.
Also Read | Insurance for RE, hydro projects in border states to rise amid conflict
There is a growing emphasis on the need for Intelligence, Surveillance, and Reconnaissance (ISR) capabilities. Mehta explained, 'We believe it's crucial to have the capability to find, locate, and designate targets that are important for our national security. That's where ISR capabilities can play a vital role."
In addition, armed drones and ISR are expected to be increasingly leveraged for retaliatory actions.
'What's very clear to us is that drones are going to be a de facto part of the infrastructure deployed for security and governance," said Mehta, emphasising the evolving role of drones in national defence.
Investors like Cornerstone Ventures are doubling down on their belief in the long-term value of drones for national security. Cornerstone Ventures has backed NewSpace Research & Technologies, a key manufacturer in India's defence drone sector and co-developer of the indigenously built kamikaze drones, recently deployed across the border, according to media reports.
"Large corporations in the defence space typically offer a bouquet of services, and when there's a ₹10,000– ₹20,000 crore defence budget, about 90% of it goes to those major players. But that's exactly where the innovation and unique strengths of startups come in," said Abhishek Prasad, managing partner at Cornerstone Ventures. These niche innovations can be crucial and often lead to partnerships with bigger players, who value the depth of expertise smaller firms bring, Prasad added.
Even so, the road to profitability remains uncertain, as procurement processes continue to evolve—especially since larger players like Tata Advanced Systems Ltd and Adani Defence continue to dominate the space. Aerial platforms remain the focal point of this shift, leaving smaller and emerging firms to carve out niche advantages in a highly-competitive environment.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Standard

34 minutes ago

• Business Standard

Decision on merger with Biocon Biologics soon, says Siddharth Mittal

We are talking about the GLP-1 opportunity and our strong franchise in insulins. There is a huge demand in the global diabetes-obesity segment, said Siddharth Mittal Sohini Das Mumbai Listen to This Article Biocon successfully raised ₹4,500 crore through a qualified institutional placement (QIP) last week that saw strong interest from both Indian and global investors. It is also considering a merger of Biocon Biologics with Biocon to tap into business and scientific synergies rather than listing Biocon Biologics. In a virtual interaction with Sohini Das, Siddharth Mittal, chief executive officer (CEO) and managing director (MD) of Biocon outlined his plans. Edited excerpts: Your QIP was successful. What do you plan to do with the proceeds? There was very strong investor demand. The Board had approved raising up to ₹4,500 crore in one,

Business Standard

34 minutes ago

• Business Standard

Influx Healthtech IPO booked 200x; check allotment, GMP, listing date

Influx Healthtech IPO allotment status: The basis of allotment of shares for Influx Healthtech is expected to be finalised today, Monday, June 23, 2025. The initial public offering (IPO) of Influx Healthtech, which closed for subscription on Friday, June 20, received a robust response from investors, with the offering being over subscribed by over 201 times. Investors bid for 817.53 million equity shares, which was 201.4 times the public issue size of 4.05 million shares, through 220,338 applications. After the allotment process is completed, investors can verify their IPO allotment status by visiting the official websites of the National Stock Exchange (NSE) and Maashitla Securities, the designated registrar for the Influx Healthtech IPO. Alternatively, they can use the direct links provided below to check their allotment status online: Check Influx Healthtech IPO allotment status on NSE: Check Influx Healthtech IPO allotment status on Maashitla Securities: Influx Healthtech IPO grey market premium (GMP) The unlisted shares of Influx Healthtech were trading at ₹118 in the grey market, commanding a premium of ₹22 or 22.3 per cent compared to the upper price band of ₹96 per share, according to sources tracking unofficial markets. Influx Healthtech IPO details The Mumbai-based company aims to raise ₹58.57 crore through a combination of a fresh issue of 5 million equity shares and an offer for sale (OFS) of 1.1 million equity shares at a price band of ₹91-96 per share. Shares of Influx Healthtech are scheduled to be listed on the NSE SME platform on Wednesday, June 25. Rarever Financial Advisors is the sole book-running lead manager. According to the red herring prospectus (RHP), the company intends to use the net fresh issue proceeds for the set up of the manufacturing facility Nutraceutical Division, a manufacturing facility for the Veterinary Food Division; purchase of machinery for Homecare and Cosmetic Division, and general corporate purposes. About Influx Healthtech Incorporated in 2020, Mumbai-based Influx Healthtech is a healthcare-focused company specialising in contract manufacturing. It operates a manufacturing facility located in Thane, Maharashtra. The company produces Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, care products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables.

Business Standard

34 minutes ago

• Business Standard

World braces for Iran's response after US airstrikes signal new era

The unprecedented US airstrikes on Iran have set traders and governments worldwide on edge, as the Islamic Republic warns of retaliation and Israel shows no sign of letting up in its assault. President Donald Trump's decision to deploy bunker-busting bombs, Washington's first direct military action against Iran after decades of hostility, has pushed the Middle East into uncharted territory and raised geopolitical risk in a world economy already facing severe uncertainty over his trade war. Oil rose almost 6 per cent when markets opened Monday morning in Asia, with analysts warning $100 a barrel is in sight depending on Iran's further response to the conflict, which began June 13 with a surprise attack by Israel. The US dollar pushed higher, stock futures fell and Bitcoin slid below $100,000 for the first time since early May. At the United Nations on Sunday, Iranian Ambassador Amir Saeid Iravani told an emergency Security Council meeting that the 'timing nature and scale' of Tehran's response 'will be decided by its armed forces.' Foreign Minister Abbas Araghchi earlier said the country reserves all options to respond. The Islamic Revolutionary Guard Corps, which answers to the Iran's supreme leader, signaled US military bases in the region could be targeted. Trump has vowed to meet any retaliation with force 'far greater' than the US strikes on the nuclear sites. He also floated the possibility of regime change in Iran, although US and Israeli officials Sunday stressed that isn't their aim. Police in New York, Washington and Los Angeles increased patrols at religious institutions, diplomatic facilities and public spaces. Officials cited no immediate credible threats but highlighted the need for vigilance. The Department of Homeland Security said the Israel-Iran war has placed the US in a 'heightened threat environment' through Sept. 22. It's still unclear how successful the US strikes were in eliminating Iran's most heavily protected enrichment site at Fordow. The head of the International Atomic Energy Agency, which officially has the task of monitoring Iran's program, told the UN Security Council on Sunday that no one yet knows the condition of the facility, nor the location of Iran's more than 400 kilograms of uranium enriched to 60 per cent. Any move by Tehran to harass traffic through the Strait of Hormuz, a major artery for global crude and natural gas, has raised the specter of a spike in energy prices at a fragile moment for the global economy. 'An expanding conflict adds to the risk of higher oil prices and an upward impulse to inflation,' Bloomberg Economics analysts including Ziad Daoud wrote in a report. Naval forces in the region warned that ships, especially US-linked vessels, could be at heightened risk. Greece, home to more oil-tanker capacity than any other nation, cautioned its ship owners to think again if they're considering entering the Persian Gulf. Two supertankers both capable of hauling about 2 million barrels of crude U-turned in the Strait of Hormuz, entering the waterway then abruptly changing course on Sunday. British Airways and Singapore Airlines canceled flights to the Persian Gulf, increasing aviation disruptions in the region. While the US action was condemned by the likes of Russia and China, even allies such as UK and France distanced themselves from Trump's decision. Iran, meanwhile, finds itself isolated. Tehran's top allies — Russia and China — are offering only rhetorical support, while the militia groups Tehran has armed and funded for years are refusing or unable to enter the fight. Israeli Prime Minister Benjamin Netanyahu pledged in a news conference to continue Israel's military campaign in Iran as well as in the Gaza Strip. The Israel Defense Forces said Sunday it hit a surface-to-air missile launcher in Tehran, while in western Iran, Israeli jets struck infrastructure for storage and missile launches as well as satellites and military radar sites.